Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Germing

Showing results (61-70 of 126) with videos related to

Pageof 13
Sort By:
Oncology Reports|April 18, 2000
Transdermal fentanyl during high-dose chemotherapy and autologous stem cell supportC Strupp, T Sudhoff, U Germing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patientsT Schroeder, L Ruf, A Bernhardt, et al.
Critical Reviews in Oncology/Hematology|June 29, 2010
Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromesJ Loeffler-Ragg, U Germing, W R Sperr, et al.
Leukemia|May 18, 2007
Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulinZ Y Lim, S Killick, U Germing, et al.
Praxis|April 13, 1999
[Role of aggressive treatment strategies for myelodysplastic syndromes]C Aul, U Germing, H Minning, et al.
Leukemia & Lymphoma|July 16, 2005
The ratio between CD4+ and CD8+ cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomideC Strupp, U Germing, M Aivado, et al.
Thrombosis and Haemostasis|November 19, 1997
Double treatment of severe hepatic veno-occlusive disease after allogeneic peripheral blood progenitor cell transplantation with recombinant tissue plasminogen activatorD Söhngen, U Bauser, C Boogen, et al.
Annals of Hematology|November 21, 2022
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blastsA Kasprzak, C Assadi, K Nachtkamp, et al.
Der Radiologe|April 20, 2002
[Dynamic contrast-enhanced MRI for evaluating bone marrow microcirculation in malignant hematological diseases before and after thalidomide therapy]A Scherer, C Strupp, H J Wittsack, et al.
Infection|August 29, 2012
An unusual presentation of a common infectionJ Richter, L Quintanilla-Martinez, K Bienemann, et al.
Pageof 13

Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Oncology Reports|April 18, 2000
Transdermal fentanyl during high-dose chemotherapy and autologous stem cell supportC Strupp, T Sudhoff, U Germing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2010
Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patientsT Schroeder, L Ruf, A Bernhardt, et al.
Critical Reviews in Oncology/Hematology|June 29, 2010
Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromesJ Loeffler-Ragg, U Germing, W R Sperr, et al.
Leukemia|May 18, 2007
Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulinZ Y Lim, S Killick, U Germing, et al.
Praxis|April 13, 1999
[Role of aggressive treatment strategies for myelodysplastic syndromes]C Aul, U Germing, H Minning, et al.
Leukemia & Lymphoma|July 16, 2005
The ratio between CD4+ and CD8+ cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomideC Strupp, U Germing, M Aivado, et al.
Thrombosis and Haemostasis|November 19, 1997
Double treatment of severe hepatic veno-occlusive disease after allogeneic peripheral blood progenitor cell transplantation with recombinant tissue plasminogen activatorD Söhngen, U Bauser, C Boogen, et al.
Annals of Hematology|November 21, 2022
Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blastsA Kasprzak, C Assadi, K Nachtkamp, et al.
Der Radiologe|April 20, 2002
[Dynamic contrast-enhanced MRI for evaluating bone marrow microcirculation in malignant hematological diseases before and after thalidomide therapy]A Scherer, C Strupp, H J Wittsack, et al.
Infection|August 29, 2012
An unusual presentation of a common infectionJ Richter, L Quintanilla-Martinez, K Bienemann, et al.
Pageof 13